BNP Paribas Financial Markets Acquires 36,034 Shares of The Clorox Company $CLX

Key Points

• BNP Paribas Financial Markets has increased its stake in The Clorox Company by 17.1%, owning 246,351 shares valued at approximately $36.3 million after acquiring an additional 36,034 shares in Q1.
• Clorox reported an earnings per share (EPS) of $2.87 for the last quarter, exceeding estimates, and has set its FY 2026 EPS guidance between 5.950-6.30.
• The company recently raised its quarterly dividend to $1.24, representing a 4.2% yield, and has a dividend payout ratio of 76.07%.

BNP Paribas Financial Markets increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 17.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 246,351 shares of the company's stock after buying an additional 36,034 shares during the quarter. BNP Paribas Financial Markets owned 0.20% of Clorox worth $36,275,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in Clorox by 0.4% during the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company's stock worth $2,293,135,000 after buying an additional 65,924 shares in the last quarter. Northern Trust Corp grew its holdings in Clorox by 2.3% during the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company's stock worth $225,133,000 after buying an additional 34,655 shares in the last quarter. Invesco Ltd. grew its holdings in Clorox by 7.4% during the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company's stock worth $200,512,000 after buying an additional 94,371 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Clorox by 12.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,115,772 shares of the company's stock worth $181,213,000 after buying an additional 123,200 shares in the last quarter. Finally, Hsbc Holdings PLC grew its holdings in Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock worth $159,699,000 after buying an additional 589,544 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CLX shares. Jefferies Financial Group decreased their price target on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday, June 26th. UBS Group cut their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Citigroup reissued a "neutral" rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. JPMorgan Chase & Co. cut their price objective on Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Finally, Wells Fargo & Company boosted their price objective on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Clorox has a consensus rating of "Reduce" and an average price target of $143.36.

Clorox Price Performance

CLX traded up $1.75 during trading on Thursday, reaching $124.66. 2,753,689 shares of the company were exchanged, compared to its average volume of 1,663,434. The company's 50-day moving average is $123.87 and its two-hundred day moving average is $133.78. The company has a market cap of $15.25 billion, a price-to-earnings ratio of 19.12, a P/E/G ratio of 0.94 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm's quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th were paid a $1.24 dividend. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. This is an increase from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is currently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.